FDA Issues Latest Draft Guidance on the Use of Real-World Data - National Law Review

Retrieved on: 2021-12-28 18:55:41

Tags for this article:

Food and Drug Administration

Clinical research

Investigational New Drug

Real World Evidence

Michael R. Taylor

u.s. food and drug administration

Click the tags to see associated articles and topics

FDA Issues Latest Draft Guidance on the Use of Real-World Data - National Law Review. View article details on hiswai:

Excerpt

... benefits or risks of a medical product derived from analysis of RWD” and RWD as “data relating to patient health status and/or the delivery of ...

Article found on: www.natlawreview.com

View Original Article